0000885590-12-000026.txt : 20120426
0000885590-12-000026.hdr.sgml : 20120426
20120426164533
ACCESSION NUMBER: 0000885590-12-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120424
FILED AS OF DATE: 20120426
DATE AS OF CHANGE: 20120426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pearson J. Michael
CENTRAL INDEX KEY: 0001426004
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 12784201
MAIL ADDRESS:
STREET 1: 7150 MISSISSAUGA ROAD
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N8M5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4787 LEVY STREET
STREET 2: MONTREAL
CITY: QUEBEC
STATE: A8
ZIP: H4R 2P9
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 4787 LEVY STREET
STREET 2: MONTREAL
CITY: QUEBEC
STATE: A8
ZIP: H4R 2P9
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0305
4
2012-04-24
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001426004
Pearson J. Michael
4787 LEVY STREET
MONTREAL
A8
H4R 2P9
QUEBEC, CANADA
1
1
0
0
Chief Executive Officer
Common Stock, no par values
2012-04-24
4
F
0
101877
0
D
6488430
D
Represents common shares withheld to satisfy certain tax obligations at the time of release.
This number represents common shares purchased by the Reporting Person, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.
by: Nicholas Zanoni for J. Michael Pearson
2012-04-26